Literature DB >> 12810440

Factors influencing uptake of influenza vaccination in patients with rheumatoid arthritis.

M J Bridges, D Coady, C A Kelly, J Hamilton, C Heycock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12810440      PMCID： PMC1754592          DOI： 10.1136/ard.62.7.685

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  15 in total

1.  Anti-tumor necrosis factor therapy and influenza: keeping it in perspective.

Authors:  Matt Shale; Markus Czub; Gilaad G Kaplan; Remo Panaccione; Subrata Ghosh
Journal:  Therap Adv Gastroenterol       Date:  2010-05       Impact factor: 4.409

2.  Preventive influenza vaccination for patients with rheumatoid arthritis. A need for an international campaign.

Authors:  L Koutsogeorgopoulou; C Antoniadis; D Vassilopoulos; D Kassimos
Journal:  Clin Rheumatol       Date:  2008-10-25       Impact factor: 2.980

3.  Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers.

Authors:  I Fomin; D Caspi; V Levy; N Varsano; Y Shalev; D Paran; D Levartovsky; I Litinsky; I Kaufman; I Wigler; E Mendelson; O Elkayam
Journal:  Ann Rheum Dis       Date:  2005-07-13       Impact factor: 19.103

4.  An audit of influenza vaccination status in adults with inflammatory bowel disease.

Authors:  Neeraj Narula; Amit S Dhillon; Usha Chauhan; John K Marshall
Journal:  Can J Gastroenterol       Date:  2012-09       Impact factor: 3.522

Review 5.  Should my patient with inflammatory bowel disease on immunosuppressive therapy be vaccinated against influenza virus?

Authors:  Neerja Narula; Deborah L R Yamamura; John K Marshall
Journal:  Can J Gastroenterol       Date:  2010-02       Impact factor: 3.522

6.  Immunization history of children with inflammatory bowel disease.

Authors:  Ing Shian Soon; Jennifer C C deBruyn; Iwona Wrobel
Journal:  Can J Gastroenterol       Date:  2013-04       Impact factor: 3.522

7.  Safety and immunogenicity of co-administered MF59-adjuvanted 2009 pandemic and plain 2009-10 seasonal influenza vaccines in rheumatoid arthritis patients on biologicals.

Authors:  F Milanetti; V Germano; R Nisini; I Donatelli; A Di Martino; M Facchini; C Ferlito; A Cappella; D Crialesi; S Caporuscio; R Biselli; F Rossi; S Salemi; R D'Amelio
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

8.  The delivery of evidence-based preventive care for older Americans with arthritis.

Authors:  Jeffrey R Curtis; Tarun Arora; Pongthorn Narongroeknawin; Allison Taylor; Clifton O Bingham; Jack Cush; Kenneth G Saag; Monika Safford; Elizabeth Delzell
Journal:  Arthritis Res Ther       Date:  2010-07-16       Impact factor: 5.156

9.  Predictors of Influenza Vaccination in Early Rheumatoid Arthritis 2017-2021: Results From the Canadian Early Arthritis Cohort.

Authors:  Viviane Ta; Orit Schieir; Marie-France Valois; Ines Colmegna; Carol Hitchon; Louis Bessette; Glen Hazlewood; Carter Thorne; Janet Pope; Gilles Boire; Diane Tin; Edward C Keystone; Vivian P Bykerk; Susan J Bartlett
Journal:  ACR Open Rheumatol       Date:  2022-03-29

10.  An audit of influenza and pneumococcal vaccination in rheumatology outpatients.

Authors:  Evin Sowden; William S Mitchell
Journal:  BMC Musculoskelet Disord       Date:  2007-07-04       Impact factor: 2.362
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.